Cancer Policy Zongertinib, dostarlimab chosen in second batch of National Priority Vouchers recipients November 07, 2025Vol.51 No.41By Jacquelyn Cobb
Cancer Policy American Academy of Pediatrics: Leucovorin is not recommended for routine use in autistic children November 07, 2025Vol.51 No.41By Sara Willa Ernst
Cancer Policy White House makes deal with Eli Lilly, Novo Nordisk to lower weight loss drug prices and begin Medicare coverage November 07, 2025Vol.51 No.41By Jacquelyn Cobb
Cancer Policy Paychecks stop for HHS workers as shutdown continues October 31, 2025Vol.51 No.40By Claire Marie Porter
Cancer Policy NEJM, public health group to launch alternate publication to CDC’s MMWR October 31, 2025Vol.51 No.40By Claire Marie Porter
Cancer Policy Senators, nonprofits respond to Trump’s avowed support for IVF October 31, 2025Vol.51 No.40By Claire Marie Porter
Cancer Policy Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting October 24, 2025Vol.51 No.39By Sara Willa Ernst
Cancer Policy Science advocates organize march in DC to demand impeachment of RFK Jr. October 24, 2025Vol.51 No.39By Sara Willa Ernst
Cancer Policy Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA October 24, 2025Vol.51 No.39By Claire Marie Porter
Cancer Policy Federal official claims that temporary order blocking RIFs doesn’t apply to HHS October 24, 2025Vol.51 No.39By Sara Willa Ernst
